Grants and Contributions:

Back to search
Agreement Number:
-
Agreement Value:
$150,000.00
Agreement Date:
Oct 1, 2018 - Sep 30, 2021
Description:
Metabolic signatures of triple negative breast cancer sensitivity and resistance to cyclophosphamide and doxorubicin in patient derived tumor xenografts
Organization:
Canadian Institutes of Health Research
Location:
Bethesda, US
Reference Number:
236-2018-2019-Q3-00037
Agreement Type:
Grant
Report Type:
Grants and Contributions
Recipient's Legal Name:
Velenosi, Thomas J
Research Organization:
National Cancer Institute (Bethesda, Maryland)